Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.046 USD | +0.18% | +9.95% | -4.23% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.23% | 24.67M | |
+24.62% | 48.09B | |
+46.90% | 40.62B | |
-3.14% | 40.43B | |
-6.20% | 28.36B | |
+9.47% | 24.89B | |
-20.45% | 19.01B | |
+29.16% | 12.09B | |
+0.76% | 11.88B | |
-1.07% | 11.8B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Lumos Pharma : HC Wainwright Adjusts Lumos Pharma's Price Target to $34 From $33, Reiterates Buy Rating